178 related articles for article (PubMed ID: 17490616)
1. Anaplastic lymphoma kinase is expressed in different subtypes of human breast cancer.
Perez-Pinera P; Chang Y; Astudillo A; Mortimer J; Deuel TF
Biochem Biophys Res Commun; 2007 Jun; 358(2):399-403. PubMed ID: 17490616
[TBL] [Abstract][Full Text] [Related]
2. The receptor protein tyrosine phosphatase (RPTP)beta/zeta is expressed in different subtypes of human breast cancer.
Perez-Pinera P; Garcia-Suarez O; Menendez-Rodriguez P; Mortimer J; Chang Y; Astudillo A; Deuel TF
Biochem Biophys Res Commun; 2007 Oct; 362(1):5-10. PubMed ID: 17706593
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.
Perez-Pinera P; Zhang W; Chang Y; Vega JA; Deuel TF
J Biol Chem; 2007 Sep; 282(39):28683-28690. PubMed ID: 17681947
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.
Deuel TF
Biochim Biophys Acta; 2013 Oct; 1834(10):2219-23. PubMed ID: 23777859
[TBL] [Abstract][Full Text] [Related]
5. Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin.
Pariser H; Ezquerra L; Herradon G; Perez-Pinera P; Deuel TF
Biochem Biophys Res Commun; 2005 Jul; 332(3):664-9. PubMed ID: 15925565
[TBL] [Abstract][Full Text] [Related]
6. Pleiotrophin disrupts calcium-dependent homophilic cell-cell adhesion and initiates an epithelial-mesenchymal transition.
Perez-Pinera P; Alcantara S; Dimitrov T; Vega JA; Deuel TF
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17795-800. PubMed ID: 17098867
[TBL] [Abstract][Full Text] [Related]
7. Pleiotrophin stimulates tyrosine phosphorylation of beta-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase beta/zeta.
Pariser H; Perez-Pinera P; Ezquerra L; Herradon G; Deuel TF
Biochem Biophys Res Commun; 2005 Sep; 335(1):232-9. PubMed ID: 16105548
[TBL] [Abstract][Full Text] [Related]
8. Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts.
Perez-Pinera P; Chang Y; Deuel TF
Cell Cycle; 2007 Dec; 6(23):2877-83. PubMed ID: 18156802
[TBL] [Abstract][Full Text] [Related]
9. Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta.
Meng K; Rodriguez-Peña A; Dimitrov T; Chen W; Yamin M; Noda M; Deuel TF
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2603-8. PubMed ID: 10706604
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase beta/zeta.
Polytarchou C; Hatziapostolou M; Poimenidi E; Mikelis C; Papadopoulou A; Parthymou A; Papadimitriou E
Int J Cancer; 2009 Apr; 124(8):1785-93. PubMed ID: 19058221
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.
Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A
Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199
[TBL] [Abstract][Full Text] [Related]
12. Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta.
Mikelis C; Sfaelou E; Koutsioumpa M; Kieffer N; Papadimitriou E
FASEB J; 2009 May; 23(5):1459-69. PubMed ID: 19141530
[TBL] [Abstract][Full Text] [Related]
13. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.
Stoica GE; Kuo A; Aigner A; Sunitha I; Souttou B; Malerczyk C; Caughey DJ; Wen D; Karavanov A; Riegel AT; Wellstein A
J Biol Chem; 2001 May; 276(20):16772-9. PubMed ID: 11278720
[TBL] [Abstract][Full Text] [Related]
14. Expression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesis.
Ball M; Carmody M; Wynne F; Dockery P; Aigner A; Cameron I; Higgins J; Smith SD; Aplin JD; Moore T
Placenta; 2009 Jul; 30(7):649-53. PubMed ID: 19481257
[TBL] [Abstract][Full Text] [Related]
15. Pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta as regulators of angiogenesis and cancer.
Papadimitriou E; Pantazaka E; Castana P; Tsalios T; Polyzos A; Beis D
Biochim Biophys Acta; 2016 Dec; 1866(2):252-265. PubMed ID: 27693125
[TBL] [Abstract][Full Text] [Related]
16. Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase.
Bowden ET; Stoica GE; Wellstein A
J Biol Chem; 2002 Sep; 277(39):35862-8. PubMed ID: 12107166
[TBL] [Abstract][Full Text] [Related]
17. Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.
Stylianou DC; Auf der Maur A; Kodack DP; Henke RT; Hohn S; Toretsky JA; Riegel AT; Wellstein A
Oncogene; 2009 Sep; 28(37):3296-306. PubMed ID: 19633684
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration.
Lampropoulou E; Logoviti I; Koutsioumpa M; Hatziapostolou M; Polytarchou C; Skandalis SS; Hellman U; Fousteris M; Nikolaropoulos S; Choleva E; Lamprou M; Skoura A; Megalooikonomou V; Papadimitriou E
Sci Rep; 2018 Apr; 8(1):5893. PubMed ID: 29651006
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of Receptor Protein Tyrosine Phosphatase β/ζ (PTPRZ1) modulates behavioral responses to ethanol.
Fernández-Calle R; Vicente-Rodríguez M; Pastor M; Gramage E; Di Geronimo B; Zapico JM; Coderch C; Pérez-García C; Lasek AW; de Pascual-Teresa B; Ramos A; Herradón G
Neuropharmacology; 2018 Jul; 137():86-95. PubMed ID: 29753117
[TBL] [Abstract][Full Text] [Related]
20. Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy.
Li R; Morris SW
Med Res Rev; 2008 May; 28(3):372-412. PubMed ID: 17694547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
